XML 53 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 90 Months Ended 114 Months Ended
Jun. 30, 2015
Dec. 31, 2013
Nov. 14, 2013
Jun. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2023
Jun. 30, 2023
Jun. 05, 2023
Oct. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Granted (in shares)             0          
Exercises in period, intrinsic value             $ 836,000          
Compensation cost not yet recognized, options       $ 91,000 $ 91,000   91,000 $ 91,000 $ 91,000 $ 91,000    
Stock repurchase program, authorized amount                       $ 100,000
Repurchase of common stock (in shares)               3,221,724        
Repurchase of common stock         5,080,000 $ 2,519,000   $ 64,044,000        
Remaining capacity under Share Repurchase Program       35,956,000 35,956,000   $ 35,956,000 35,956,000 35,956,000 35,956,000    
Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Compensation cost not yet recognized, period for recognition             8 months 15 days          
Restricted Stock Units and Performance Stock Units                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Compensation cost not yet recognized, period for recognition             2 years 9 months 3 days          
Compensation cost not yet recognized, non-option       $ 279,725,000 $ 279,725,000   $ 279,725,000 $ 279,725,000 $ 279,725,000 $ 279,725,000    
The 2005 Stock Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, capital shares reserved for future issuance (in shares)   14,139,957                    
Granted (in shares)                   0    
Shares available for grant (in shares)       0 0   0 0 0 0    
The 2005 Stock Plan | Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Vesting period (in years)   4 years                    
The 2013 Omnibus Equity Award Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, capital shares reserved for future issuance (in shares)     5,713,899                  
Vesting period (in years)     4 years                  
Granted (in shares)       0                
Shares available for grant (in shares)       0 0   0 0 0 0    
Percentage of outstanding stock reserved for grant     4.00%                  
Percentage of outstanding stock maximum     5.00%                  
Capital shares reserved for future issuance, annual increase, maximum (in shares)       27,579,672 27,579,672   27,579,672 27,579,672 27,579,672 27,579,672    
Polyrize Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Shares available for grant (in shares)       0 0   0 0 0 0    
2023 Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, capital shares reserved for future issuance (in shares)                     5,500,000  
2015 ESPP                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Maximum employee subscription rate 15.00%                      
Purchase price of common stock, percent 85.00%                      
Number of shares authorized (in shares) 1,500,000                      
Percent of shares increase, employee stock purchase plan 1.00%                      
Common stock availability threshold, Employee Stock Purchase Plan 2.00%                      
Shares increase threshold, employee stock purchase plan (in shares) 1,200,000                      
Number of additional shares authorized (in shares)                 3,402,705